Lung Cancer Screening

A Population Approach

Gregory C. Kane, Julie A. Barta, Ronald E. Myers, Nathaniel R. Evans III (Herausgeber)

Buch | Hardcover

XIV, 390 Seiten

2023 | 1st ed. 2023
Springer International Publishing (Verlag)
978-3-031-33595-2 (ISBN)

Artikel merken

lt;p>This book is a comprehensive guide to lung cancer screening for clinicians, healthcare systems, community leaders, and public health officials with the hope of creating a more equitable landscape in both lung cancer screening and lung cancer-related outcomes, at local, state, and national levels. Authors take a new approach to primary and secondary lung cancer prevention that is in the early stages of adoption in the United States. The last decade ushered in recognition of screening as an effective intervention, but unfortunately, despite the wide acceptance of the importance of this new screening modality, nationally, not more than 5% of eligible subjects have undergone screening to date in the United States, although in some states uptake has reached as high as 16%. As is common with any new preventive cancer screening, racial and socioeconomic disparities emerge in utilization, stage at diagnosis, and mortality. Over time, these disparities decline, but consequential differences endure. Therefore, it is critical to establish equitable screening practices.

The true measure of the effectiveness of any lung cancer screening program needs to be viewed through the lens of its impact on populations, including those most affected by the morbidity and mortality of smoking-related illness and lung cancer. As such, this book emphasizes a number of important public health topics, including community outreach to vulnerable populations, social justice issues, addressing stigma and fatalism in the general community, and the use of geocoding to assess a program's impact at a population level. This book weaves traditional topics related to lung cancer screening, such as promoting initial and repeat screening, interpreting Lung RADs, and managing the follow-up of findings, into the population perspective in order to present a unified, comprehensive approach to the subject. Further, it serves as a guide that health systems, health care professionals, community leaders, and other stakeholders can use to achieve the promise of lung cancer screening.

lt;p>Gregory C. Kane, MD, MACP

The Jefferson-National Jewish Health Korman Respiratory Institute

Division of Pulmonary and Critical Care Medicine

Department of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA, USA

Julie A. Barta, MD, ATSF

The Jefferson-National Jewish Health Korman Respiratory Institute

Division of Pulmonary and Critical Care Medicine

Department of Medicine

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA, USA

Ronald E. Myers, DSW, PhD, FSBM

Division of Population Science

Department of Medical Oncology

Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, PA, USA

Nathaniel R. Evans III, MD, FACS, FCCP

The Jefferson-National Jewish Health Korman Respiratory Institute

Division of Thoracic Surgery

Department of Surgery

Sidney Kimmel Medical College at Thomas Jefferson University

Philadelphia, PA, USAu

SECTION 1: INTRODUCTIONChapter 1: The Promise of Lung Cancer ScreeningChapter 2: A Brief History of Lung Cancer ScreeningChapter 3: Stigma and Fatalism in Lung CancerChapter 4: Screening Eligibility, Education, and Shared Decision MakingChapter 5: Smoking Cessation in a Lung Cancer Screening ProgramChapter 6: Why Achieving Health Equity in Lung Cancer Screening is SoSECTION 2: APPLYING A LEARNING COMMUNITY MODELChapter 7: A Health System Learning CommunityChapter 8: Different Approaches for Offering Lung Cancer ScreeningChapter 9: Identifying Patients Eligible for Lung Cancer ScreeningChapter 10: Patient Outreach and Provider Support in Lung Cancer ScreeningChapter 11: Shared Decision Making in Lung Cancer ScreeningChapter 12: Advances in Tobacco TreatmentSECTION 3: ORGANIZING A QUALITY PROGRAMChapter 13: Organizational Workflow for Lung CancerChapter 14: Lung-RADS and Radiology Reporting RequirementsChapter 15: Managing Incidental FindingsChapter 16: Leveraging the EMR for Continuous QualityChapter 17: Minimizing Harms of ScreeningChapter 18: A Multidisciplinary ApproachChapter 19: Managing Lung Cancer Screening in a Major Health Care SystemChapter 20: Cost ConsiderationsSECTION 4: TAKING CARE OF THE PATIENTChapter 21: Engaging Patients from Diverse Backgrounds in Lung CancerChapter 22: Modern Management of Early-Stage Lung CancerChapter 23: The Revolution of Lung Cancer TherapeuticsSECTION 5: ENGAGING THE COMMUNITYChapter 24: Lung Cancer and Social Justice - What Do I Need to Understand?Chapter 25: Reaching Vulnerable Populations and Areas of NeedChapter 26: Lung Cancer Myths and How Do I Address Them?Chapter 27: How to Expand Your Program's Reach Beyond the Healthcare System and Into the CommunitySECTION 6: DETERMINING IMPACT AT THE POPULATION LEVELChapter 28: Lung Cancer Screening-Addressing DisparitiesChapter 29: Geocoding and Assessing a Program's ImpactChapter 30: Partnering with Stakeholders for Broad ImpactSECTION 7: ON THE HORIZON: WHAT LIES AHEAD IN LUNG CANCER SCREENINGChapter 31: Assessing Health Systems' Preparedness for Addressing Lung Cancer Screening at a Population Level Chapter 32: New Partnerships in Reaching Unique PopulationsChapter 33: Where Do We Go From Here?Chapter 34: Imaging an Equitable Lung Cancer Screening

Erscheinungsdatum	26.08.2023
Zusatzinfo	XIV, 390 p. 50 illus., 41 illus. in color.
Verlagsort	Cham
Sprache	englisch
Maße	155 x 235 mm
Gewicht	762 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete
Schlagworte	disparity • Impact • Learning Community Model • Mortality • Outreach • patient approach • risk factors
ISBN-10	3-031-33595-3 / 3031335953
ISBN-13	978-3-031-33595-2 / 9783031335952
Zustand	Neuware